Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Research study shows how proteins may develop new ways of treating breast cancer

14.03.2008
A major research study based at the University of Southampton is looking into how specific proteins, which are involved in the growth and survival of breast cancer cells, may help to develop new ways of treating breast cancer.

The study, led by Dr Jeremy Blaydes, will explore how one specific group of molecules called C-Terminal Binding Proteins (CtBPs) prevent breast cancer cell death and encourage cell growth.

Scientists have shown that in breast cancer cells, CtBPs act to prevent another molecule - p53, which is vital in causing cell death, from doing its job, so breast cancer cells continue to grow rather than die.

Dr Blaydes study will investigate exactly how CtBPs keep breast cancer cells alive and then develop a way of experimentally changing CtBPs in order to promote the death of breast cancer cells.

... more about:
»Blaydes »CtBP »cancer cells »proteins

Dr Jeremy Blaydes, of the Cancer Sciences Division in the University's School of Medicine, said: "What we can show is that cancer cells need CtBPs to stay alive, so we've devised a laboratory technique to prevent cancer cells producing these proteins. We're trying to understand what it is about CtBPs that the cancer cells need, so we can develop therapies to prevent cancers from developing.

"Breast cancer not only affects those diagnosed with the disease, but the lives of friends and family, so it is vitally important that we are utterly committed to working towards improved diagnosis, treatment, prevention and cure."

The research is funded over three years by the Breast Cancer Campaign (BCC), a charity which specialises in funding independent breast cancer research throughout the UK. Dr Blaydes has discovered with previous BCC funding that current chemotherapies can work, in part, by inhibiting CtBP function in breast cancer cells.

Dr Blaydes adds: "By knowing more about CtBPs, we hope to improve our knowledge of how to use chemotherapy treatments more effectively."

Glenn Harris | alfa
Further information:
http://www.soton.ac.uk

Further reports about: Blaydes CtBP cancer cells proteins

More articles from Life Sciences:

nachricht Toward a 'smart' patch that automatically delivers insulin when needed
18.01.2017 | American Chemical Society

nachricht 127 at one blow...
18.01.2017 | Stiftung Zoologisches Forschungsmuseum Alexander Koenig, Leibniz-Institut für Biodiversität der Tiere

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

A big nano boost for solar cells

18.01.2017 | Power and Electrical Engineering

Glass's off-kilter harmonies

18.01.2017 | Materials Sciences

Toward a 'smart' patch that automatically delivers insulin when needed

18.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>